A 10-year experience with bacteriology of acute thoracic empyema: Emphasis on Klebsiella pneumoniae in patients with diabetes mellitus

To provide an updated evaluation of the bacteriology of acute thoracic empyema for more efficacious treatment. : The medical and microbiological records of all patients who received a diagnosis of acute thoracic empyema were reviewed. Based on the bacteria isolated from the pleural fluid, the patien...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chest 2000-06, Vol.117 (6), p.1685-1689
Hauptverfasser: CHEN, K.-Y, HSUEH, M. P.-R, LIAW, M. Y.-S, YANG, P.-C, LUH, K.-T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1689
container_issue 6
container_start_page 1685
container_title Chest
container_volume 117
creator CHEN, K.-Y
HSUEH, M. P.-R
LIAW, M. Y.-S
YANG, P.-C
LUH, K.-T
description To provide an updated evaluation of the bacteriology of acute thoracic empyema for more efficacious treatment. : The medical and microbiological records of all patients who received a diagnosis of acute thoracic empyema were reviewed. Based on the bacteria isolated from the pleural fluid, the patients were classified into the following four groups: aerobic or facultative Gram-positive; aerobic Gram-negative; anaerobic; and mixed. A university-affiliated tertiary medical center. From January 1989 to December 1998, 171 patients with a diagnosis of acute thoracic empyema were treated. A comparative analysis of the isolates from pleural effusions, the mean length of hospital stay, the mean duration of chest tube drainage, the mean duration between the onset of symptoms and the establishment of diagnosis, treatment efficacy, and the need for subsequent intervention was performed. A total of 163 microorganisms were isolated from the pleural fluid of 139 patients. These patients were classified according to the following types of isolates: aerobic or facultative Gram-positive (n = 47); aerobic Gram-negative (n = 59); anaerobic (n = 14); and mixed (n = 19). Klebsiella pneumoniae was the most commonly isolated pathogen (24. 4%) and was strongly associated with a diagnosis of diabetes mellitus. The mortality rate of patients with aerobic Gram-negative bacilli isolated was the highest (22.0%), followed by those with mixed pathogens isolated (15.7%), aerobic or facultative Gram-positive (6.4%), and anaerobic (0%). The increasing incidence of acute thoracic empyema caused by Gram-negative bacilli, especially by K pneumoniae, has become an increasing problem. The isolation of aerobic Gram-negative bacilli or multiple pathogens from pleural fluid is associated with a poor prognosis and indicates a need for more aggressive antimicrobial chemotherapy.
doi_str_mv 10.1378/chest.117.6.1685
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71201470</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>56087367</sourcerecordid><originalsourceid>FETCH-LOGICAL-p263t-ae1e6b6b004044e4645c0c07e3611e373fddd8b3329a0c1555d116063f253ed13</originalsourceid><addsrcrecordid>eNpd0EFr1UAQB_BFFPus3j3JIuItrzOZZJN4K6VqseClnsNkM_FtSbIxu0HfF_Bzu9InQk_DDD_-M4xSrxH2SFV9YQ8S4h6x2ps9mrp8onbYEGZUFvRU7QAwz8g0-Zl6EcI9pB4b81ydIdRlXQDt1O9LjZAdhVctvxZZncxW9E8XD7pjG9PAj_77UftBs92i6HjwK1tntUzLUSb-oK-n5cDBBe1n_WWULjgZR9bLLNvkZ8ei3awXjik6hofo3nEnUYKeEnVxCy_Vs4HHIK9O9Vx9-3h9d_U5u_366ebq8jZbckMxY0ExnekACigKKUxRWrBQCRlEoYqGvu_rjihvGCyWZdkjGjA05CVJj3Su3j_kLqv_saXntZML9u-9s_gttBXmgEUFCb59BO_9ts7ptjZP22tokBJ6c0JbN0nfLqubeD22_96bwLsT4GB5HFaerQv_HTU5EdIf8v6KaA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200480913</pqid></control><display><type>article</type><title>A 10-year experience with bacteriology of acute thoracic empyema: Emphasis on Klebsiella pneumoniae in patients with diabetes mellitus</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>CHEN, K.-Y ; HSUEH, M. P.-R ; LIAW, M. Y.-S ; YANG, P.-C ; LUH, K.-T</creator><creatorcontrib>CHEN, K.-Y ; HSUEH, M. P.-R ; LIAW, M. Y.-S ; YANG, P.-C ; LUH, K.-T</creatorcontrib><description>To provide an updated evaluation of the bacteriology of acute thoracic empyema for more efficacious treatment. : The medical and microbiological records of all patients who received a diagnosis of acute thoracic empyema were reviewed. Based on the bacteria isolated from the pleural fluid, the patients were classified into the following four groups: aerobic or facultative Gram-positive; aerobic Gram-negative; anaerobic; and mixed. A university-affiliated tertiary medical center. From January 1989 to December 1998, 171 patients with a diagnosis of acute thoracic empyema were treated. A comparative analysis of the isolates from pleural effusions, the mean length of hospital stay, the mean duration of chest tube drainage, the mean duration between the onset of symptoms and the establishment of diagnosis, treatment efficacy, and the need for subsequent intervention was performed. A total of 163 microorganisms were isolated from the pleural fluid of 139 patients. These patients were classified according to the following types of isolates: aerobic or facultative Gram-positive (n = 47); aerobic Gram-negative (n = 59); anaerobic (n = 14); and mixed (n = 19). Klebsiella pneumoniae was the most commonly isolated pathogen (24. 4%) and was strongly associated with a diagnosis of diabetes mellitus. The mortality rate of patients with aerobic Gram-negative bacilli isolated was the highest (22.0%), followed by those with mixed pathogens isolated (15.7%), aerobic or facultative Gram-positive (6.4%), and anaerobic (0%). The increasing incidence of acute thoracic empyema caused by Gram-negative bacilli, especially by K pneumoniae, has become an increasing problem. The isolation of aerobic Gram-negative bacilli or multiple pathogens from pleural fluid is associated with a poor prognosis and indicates a need for more aggressive antimicrobial chemotherapy.</description><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1378/chest.117.6.1685</identifier><identifier>PMID: 10858403</identifier><identifier>CODEN: CHETBF</identifier><language>eng</language><publisher>Northbrook, IL: American College of Chest Physicians</publisher><subject>Acute Disease ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents - therapeutic use ; Antibiotics ; Bacteria ; Bacterial diseases ; Bacterial diseases of the respiratory system ; Bacteriological Techniques ; Bacteriology ; Biological and medical sciences ; Chest Tubes ; Child ; Child, Preschool ; Chronic obstructive pulmonary disease ; Combined Modality Therapy ; Diabetes ; Diabetes Mellitus - microbiology ; Diabetes Mellitus - mortality ; Diabetes Mellitus - therapy ; Empyema, Pleural - microbiology ; Empyema, Pleural - mortality ; Empyema, Pleural - therapy ; Female ; Fibrinolytic Agents - therapeutic use ; Hospitals ; Human bacterial diseases ; Humans ; Infant ; Infectious diseases ; Klebsiella Infections - microbiology ; Klebsiella Infections - mortality ; Klebsiella Infections - therapy ; Klebsiella pneumoniae - drug effects ; Klebsiella pneumoniae - pathogenicity ; Lung diseases ; Male ; Medical sciences ; Microbial Sensitivity Tests ; Microorganisms ; Middle Aged ; Mortality ; Opportunistic Infections - microbiology ; Opportunistic Infections - mortality ; Opportunistic Infections - therapy ; Ostomy ; Pathogens ; Patients ; Pleural effusion ; Retrospective Studies ; Streptococcus infections ; Survival Rate ; Thoracentesis ; Virulence</subject><ispartof>Chest, 2000-06, Vol.117 (6), p.1685-1689</ispartof><rights>2000 INIST-CNRS</rights><rights>Copyright American College of Chest Physicians Jun 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1392331$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10858403$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CHEN, K.-Y</creatorcontrib><creatorcontrib>HSUEH, M. P.-R</creatorcontrib><creatorcontrib>LIAW, M. Y.-S</creatorcontrib><creatorcontrib>YANG, P.-C</creatorcontrib><creatorcontrib>LUH, K.-T</creatorcontrib><title>A 10-year experience with bacteriology of acute thoracic empyema: Emphasis on Klebsiella pneumoniae in patients with diabetes mellitus</title><title>Chest</title><addtitle>Chest</addtitle><description>To provide an updated evaluation of the bacteriology of acute thoracic empyema for more efficacious treatment. : The medical and microbiological records of all patients who received a diagnosis of acute thoracic empyema were reviewed. Based on the bacteria isolated from the pleural fluid, the patients were classified into the following four groups: aerobic or facultative Gram-positive; aerobic Gram-negative; anaerobic; and mixed. A university-affiliated tertiary medical center. From January 1989 to December 1998, 171 patients with a diagnosis of acute thoracic empyema were treated. A comparative analysis of the isolates from pleural effusions, the mean length of hospital stay, the mean duration of chest tube drainage, the mean duration between the onset of symptoms and the establishment of diagnosis, treatment efficacy, and the need for subsequent intervention was performed. A total of 163 microorganisms were isolated from the pleural fluid of 139 patients. These patients were classified according to the following types of isolates: aerobic or facultative Gram-positive (n = 47); aerobic Gram-negative (n = 59); anaerobic (n = 14); and mixed (n = 19). Klebsiella pneumoniae was the most commonly isolated pathogen (24. 4%) and was strongly associated with a diagnosis of diabetes mellitus. The mortality rate of patients with aerobic Gram-negative bacilli isolated was the highest (22.0%), followed by those with mixed pathogens isolated (15.7%), aerobic or facultative Gram-positive (6.4%), and anaerobic (0%). The increasing incidence of acute thoracic empyema caused by Gram-negative bacilli, especially by K pneumoniae, has become an increasing problem. The isolation of aerobic Gram-negative bacilli or multiple pathogens from pleural fluid is associated with a poor prognosis and indicates a need for more aggressive antimicrobial chemotherapy.</description><subject>Acute Disease</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Bacteria</subject><subject>Bacterial diseases</subject><subject>Bacterial diseases of the respiratory system</subject><subject>Bacteriological Techniques</subject><subject>Bacteriology</subject><subject>Biological and medical sciences</subject><subject>Chest Tubes</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Combined Modality Therapy</subject><subject>Diabetes</subject><subject>Diabetes Mellitus - microbiology</subject><subject>Diabetes Mellitus - mortality</subject><subject>Diabetes Mellitus - therapy</subject><subject>Empyema, Pleural - microbiology</subject><subject>Empyema, Pleural - mortality</subject><subject>Empyema, Pleural - therapy</subject><subject>Female</subject><subject>Fibrinolytic Agents - therapeutic use</subject><subject>Hospitals</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infant</subject><subject>Infectious diseases</subject><subject>Klebsiella Infections - microbiology</subject><subject>Klebsiella Infections - mortality</subject><subject>Klebsiella Infections - therapy</subject><subject>Klebsiella pneumoniae - drug effects</subject><subject>Klebsiella pneumoniae - pathogenicity</subject><subject>Lung diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Microorganisms</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Opportunistic Infections - microbiology</subject><subject>Opportunistic Infections - mortality</subject><subject>Opportunistic Infections - therapy</subject><subject>Ostomy</subject><subject>Pathogens</subject><subject>Patients</subject><subject>Pleural effusion</subject><subject>Retrospective Studies</subject><subject>Streptococcus infections</subject><subject>Survival Rate</subject><subject>Thoracentesis</subject><subject>Virulence</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpd0EFr1UAQB_BFFPus3j3JIuItrzOZZJN4K6VqseClnsNkM_FtSbIxu0HfF_Bzu9InQk_DDD_-M4xSrxH2SFV9YQ8S4h6x2ps9mrp8onbYEGZUFvRU7QAwz8g0-Zl6EcI9pB4b81ydIdRlXQDt1O9LjZAdhVctvxZZncxW9E8XD7pjG9PAj_77UftBs92i6HjwK1tntUzLUSb-oK-n5cDBBe1n_WWULjgZR9bLLNvkZ8ei3awXjik6hofo3nEnUYKeEnVxCy_Vs4HHIK9O9Vx9-3h9d_U5u_366ebq8jZbckMxY0ExnekACigKKUxRWrBQCRlEoYqGvu_rjihvGCyWZdkjGjA05CVJj3Su3j_kLqv_saXntZML9u-9s_gttBXmgEUFCb59BO_9ts7ptjZP22tokBJ6c0JbN0nfLqubeD22_96bwLsT4GB5HFaerQv_HTU5EdIf8v6KaA</recordid><startdate>20000601</startdate><enddate>20000601</enddate><creator>CHEN, K.-Y</creator><creator>HSUEH, M. P.-R</creator><creator>LIAW, M. Y.-S</creator><creator>YANG, P.-C</creator><creator>LUH, K.-T</creator><general>American College of Chest Physicians</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20000601</creationdate><title>A 10-year experience with bacteriology of acute thoracic empyema: Emphasis on Klebsiella pneumoniae in patients with diabetes mellitus</title><author>CHEN, K.-Y ; HSUEH, M. P.-R ; LIAW, M. Y.-S ; YANG, P.-C ; LUH, K.-T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p263t-ae1e6b6b004044e4645c0c07e3611e373fddd8b3329a0c1555d116063f253ed13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Acute Disease</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Bacteria</topic><topic>Bacterial diseases</topic><topic>Bacterial diseases of the respiratory system</topic><topic>Bacteriological Techniques</topic><topic>Bacteriology</topic><topic>Biological and medical sciences</topic><topic>Chest Tubes</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Combined Modality Therapy</topic><topic>Diabetes</topic><topic>Diabetes Mellitus - microbiology</topic><topic>Diabetes Mellitus - mortality</topic><topic>Diabetes Mellitus - therapy</topic><topic>Empyema, Pleural - microbiology</topic><topic>Empyema, Pleural - mortality</topic><topic>Empyema, Pleural - therapy</topic><topic>Female</topic><topic>Fibrinolytic Agents - therapeutic use</topic><topic>Hospitals</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infant</topic><topic>Infectious diseases</topic><topic>Klebsiella Infections - microbiology</topic><topic>Klebsiella Infections - mortality</topic><topic>Klebsiella Infections - therapy</topic><topic>Klebsiella pneumoniae - drug effects</topic><topic>Klebsiella pneumoniae - pathogenicity</topic><topic>Lung diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Microorganisms</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Opportunistic Infections - microbiology</topic><topic>Opportunistic Infections - mortality</topic><topic>Opportunistic Infections - therapy</topic><topic>Ostomy</topic><topic>Pathogens</topic><topic>Patients</topic><topic>Pleural effusion</topic><topic>Retrospective Studies</topic><topic>Streptococcus infections</topic><topic>Survival Rate</topic><topic>Thoracentesis</topic><topic>Virulence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CHEN, K.-Y</creatorcontrib><creatorcontrib>HSUEH, M. P.-R</creatorcontrib><creatorcontrib>LIAW, M. Y.-S</creatorcontrib><creatorcontrib>YANG, P.-C</creatorcontrib><creatorcontrib>LUH, K.-T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Chest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CHEN, K.-Y</au><au>HSUEH, M. P.-R</au><au>LIAW, M. Y.-S</au><au>YANG, P.-C</au><au>LUH, K.-T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A 10-year experience with bacteriology of acute thoracic empyema: Emphasis on Klebsiella pneumoniae in patients with diabetes mellitus</atitle><jtitle>Chest</jtitle><addtitle>Chest</addtitle><date>2000-06-01</date><risdate>2000</risdate><volume>117</volume><issue>6</issue><spage>1685</spage><epage>1689</epage><pages>1685-1689</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><coden>CHETBF</coden><abstract>To provide an updated evaluation of the bacteriology of acute thoracic empyema for more efficacious treatment. : The medical and microbiological records of all patients who received a diagnosis of acute thoracic empyema were reviewed. Based on the bacteria isolated from the pleural fluid, the patients were classified into the following four groups: aerobic or facultative Gram-positive; aerobic Gram-negative; anaerobic; and mixed. A university-affiliated tertiary medical center. From January 1989 to December 1998, 171 patients with a diagnosis of acute thoracic empyema were treated. A comparative analysis of the isolates from pleural effusions, the mean length of hospital stay, the mean duration of chest tube drainage, the mean duration between the onset of symptoms and the establishment of diagnosis, treatment efficacy, and the need for subsequent intervention was performed. A total of 163 microorganisms were isolated from the pleural fluid of 139 patients. These patients were classified according to the following types of isolates: aerobic or facultative Gram-positive (n = 47); aerobic Gram-negative (n = 59); anaerobic (n = 14); and mixed (n = 19). Klebsiella pneumoniae was the most commonly isolated pathogen (24. 4%) and was strongly associated with a diagnosis of diabetes mellitus. The mortality rate of patients with aerobic Gram-negative bacilli isolated was the highest (22.0%), followed by those with mixed pathogens isolated (15.7%), aerobic or facultative Gram-positive (6.4%), and anaerobic (0%). The increasing incidence of acute thoracic empyema caused by Gram-negative bacilli, especially by K pneumoniae, has become an increasing problem. The isolation of aerobic Gram-negative bacilli or multiple pathogens from pleural fluid is associated with a poor prognosis and indicates a need for more aggressive antimicrobial chemotherapy.</abstract><cop>Northbrook, IL</cop><pub>American College of Chest Physicians</pub><pmid>10858403</pmid><doi>10.1378/chest.117.6.1685</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0012-3692
ispartof Chest, 2000-06, Vol.117 (6), p.1685-1689
issn 0012-3692
1931-3543
language eng
recordid cdi_proquest_miscellaneous_71201470
source MEDLINE; Alma/SFX Local Collection
subjects Acute Disease
Adolescent
Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents - therapeutic use
Antibiotics
Bacteria
Bacterial diseases
Bacterial diseases of the respiratory system
Bacteriological Techniques
Bacteriology
Biological and medical sciences
Chest Tubes
Child
Child, Preschool
Chronic obstructive pulmonary disease
Combined Modality Therapy
Diabetes
Diabetes Mellitus - microbiology
Diabetes Mellitus - mortality
Diabetes Mellitus - therapy
Empyema, Pleural - microbiology
Empyema, Pleural - mortality
Empyema, Pleural - therapy
Female
Fibrinolytic Agents - therapeutic use
Hospitals
Human bacterial diseases
Humans
Infant
Infectious diseases
Klebsiella Infections - microbiology
Klebsiella Infections - mortality
Klebsiella Infections - therapy
Klebsiella pneumoniae - drug effects
Klebsiella pneumoniae - pathogenicity
Lung diseases
Male
Medical sciences
Microbial Sensitivity Tests
Microorganisms
Middle Aged
Mortality
Opportunistic Infections - microbiology
Opportunistic Infections - mortality
Opportunistic Infections - therapy
Ostomy
Pathogens
Patients
Pleural effusion
Retrospective Studies
Streptococcus infections
Survival Rate
Thoracentesis
Virulence
title A 10-year experience with bacteriology of acute thoracic empyema: Emphasis on Klebsiella pneumoniae in patients with diabetes mellitus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T20%3A43%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%2010-year%20experience%20with%20bacteriology%20of%20acute%20thoracic%20empyema:%20Emphasis%20on%20Klebsiella%20pneumoniae%20in%20patients%20with%20diabetes%20mellitus&rft.jtitle=Chest&rft.au=CHEN,%20K.-Y&rft.date=2000-06-01&rft.volume=117&rft.issue=6&rft.spage=1685&rft.epage=1689&rft.pages=1685-1689&rft.issn=0012-3692&rft.eissn=1931-3543&rft.coden=CHETBF&rft_id=info:doi/10.1378/chest.117.6.1685&rft_dat=%3Cproquest_pubme%3E56087367%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=200480913&rft_id=info:pmid/10858403&rfr_iscdi=true